CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

[at noodls] – IRVINE, Calif., Dec. 20, 2012 (GLOBE NEWSWIRE) — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for prenatal, pediatric and oncology, today … more

View todays social media effects on CBMXW

View the latest stocks trending across Twitter. Click to view dashboard

See who CombiMatrix is hiring next, click here to view